Literature DB >> 18651815

Staphylococcus aureus evasion of innate antimicrobial defense.

Dirk Kraus1, Andreas Peschel.   

Abstract

Bacterial pathogens colonize human body surfaces soon after birth. In order to survive the constant threat of invasion and infection, the human innate immune system has evolved several efficient mechanisms to prevent harmful microorganisms from traversing epithelial barriers. These include cationic antimicrobial peptides (CAMPs) such as defensins and the cathelicidin LL-37, bacteriolytic enzymes such as lysozyme, antimicrobial fatty acids, toxic oxygen- or nitrogen-containing molecules, the bacteriolytic complement components and further mechanisms with indirect impacts on bacterial multiplication. Staphylococcus aureus is an important human commensal and pathogen. In order to successfully establish an infection, S. aureus has evolved several mechanisms to resist the innate immune system. In this review, we focus on the mechanisms employed by S. aureus to achieve protection against antimicrobial host defense molecules with special emphasis on CAMPs. Lessons from recent studies on antimicrobial host defense molecules and cognate bacterial resistance adaptation should help in the development of more sustainable anti-infective compounds.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18651815     DOI: 10.2217/17460913.3.4.437

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  28 in total

1.  Fibrocyte-like cells recruited to the spleen support innate and adaptive immune responses to acute injury or infection.

Authors:  Tatiana Kisseleva; Maren von Köckritz-Blickwede; Donna Reichart; Shauna M McGillvray; Gerhard Wingender; Mitchell Kronenberg; Christopher K Glass; Victor Nizet; David A Brenner
Journal:  J Mol Med (Berl)       Date:  2011-04-16       Impact factor: 4.599

2.  Analysis of the effects of cigarette smoke on staphylococcal virulence phenotypes.

Authors:  Elisa K McEachern; John H Hwang; Katherine M Sladewski; Shari Nicatia; Carola Dewitz; Denzil P Mathew; Victor Nizet; Laura E Crotty Alexander
Journal:  Infect Immun       Date:  2015-03-30       Impact factor: 3.441

3.  Staphylococcus aureus stimulates neutrophil targeting chemokine expression in keratinocytes through an autocrine IL-1alpha signaling loop.

Authors:  Florina Olaru; Liselotte E Jensen
Journal:  J Invest Dermatol       Date:  2010-02-25       Impact factor: 8.551

Review 4.  Community-associated meticillin-resistant Staphylococcus aureus.

Authors:  Frank R DeLeo; Michael Otto; Barry N Kreiswirth; Henry F Chambers
Journal:  Lancet       Date:  2010-03-05       Impact factor: 79.321

Review 5.  Bone marrow-derived fibrocytes contribute to liver fibrosis.

Authors:  Jun Xu; Tatiana Kisseleva
Journal:  Exp Biol Med (Maywood)       Date:  2015-05-12

6.  VraH Is the Third Component of the Staphylococcus aureus VraDEH System Involved in Gallidermin and Daptomycin Resistance and Pathogenicity.

Authors:  Peter Popella; Sophia Krauss; Patrick Ebner; Mulugeta Nega; Julia Deibert; Friedrich Götz
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

7.  Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus.

Authors:  George Sakoulas; Cheryl Y Okumura; Wdee Thienphrapa; Joshua Olson; Poochit Nonejuie; Quang Dam; Abhay Dhand; Joseph Pogliano; Michael R Yeaman; Mary E Hensler; Arnold S Bayer; Victor Nizet
Journal:  J Mol Med (Berl)       Date:  2013-12-03       Impact factor: 4.599

8.  Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.

Authors:  Santiago Ramón-García; Ralf Mikut; Carol Ng; Serge Ruden; Rudolf Volkmer; Markus Reischl; Kai Hilpert; Charles J Thompson
Journal:  Antimicrob Agents Chemother       Date:  2013-03-11       Impact factor: 5.191

9.  Wall teichoic acid protects Staphylococcus aureus against antimicrobial fatty acids from human skin.

Authors:  Thomas Kohler; Christopher Weidenmaier; Andreas Peschel
Journal:  J Bacteriol       Date:  2009-05-08       Impact factor: 3.490

10.  The bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion.

Authors:  Christoph M Ernst; Petra Staubitz; Nagendra N Mishra; Soo-Jin Yang; Gabriele Hornig; Hubert Kalbacher; Arnold S Bayer; Dirk Kraus; Andreas Peschel
Journal:  PLoS Pathog       Date:  2009-11-13       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.